慢性HBV感染及其相关肝病患者外周血T细胞亚群的变化

王慰; 郑欢伟; 任桂芳; 冯爱东; 刘莲; 李兵顺

慢性HBV感染及其相关肝病患者外周血T细胞亚群的变化

石家庄市第五医院感染二科

基金项目:

河北省卫生厅科研基金项目(20090607)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2895
- HTML全文浏览量: 11
- PDF下载量: 637
- 被引次数: 0
出版历程
- 出版日期: 2013-04-20

Differential profiles of T-cell subsets are present in peripheral blood of patients with various progressive forms of hepatitis B infection

Research funding:

摘要

摘要:
目的观察不同临床类型HBV感染者外周血T淋巴细胞亚群的差异,探讨HBV对人体T细胞免疫的影响及其可能机制,不同类型慢性HBV感染者免疫失衡的规律。方法用流式细胞仪技术检测患者外周血T细胞亚群。慢性HBV感染者318例,其中HBV携带者8例,慢性乙型肝炎231例,肝炎后肝硬化61例,原发性肝癌18例,观察患者的T淋巴细胞亚群、HBV DNA等。同时收集22名健康志愿者的新鲜血检测T淋巴细胞亚群。结果不同临床类型HBV感染者外周血CD3+T、CD4+T、CD8+T细胞百分数低于正常对照组,差别均有统计学意义（P<0.05或P<0.01）,cd4+ p="">0.05）。结论慢性HBV感染随着病情进展,由慢性肝炎→肝硬化→肝癌,直至细胞免疫功能逐渐衰退。慢性HBV感染的不同阶段的细胞免疫紊乱各具特点,就不同类型患者应采用不同的免疫调节治疗手段。
- 肝炎病毒,乙型 /
- T淋巴细胞亚群
Abstract:
Objective To determine whether various progressive forms of hepatitis B virus (HBV) infection, from HBV carriers to chronic hepatitis B (CHB) without complication or with cirrhosis or hepatocellular carcinoma (HCC) , are associated with differential profiles of T lymphocyte subsets in peripheral blood.Methods Between 2009 and 2011, 318 HBV infections presented for treatment at our hospital, including eight HBV carriers, 231 cases of CHB, 61 cases of CHB-related cirrhosis, and 18 cases of CHB-related HCC.Peripheral blood samples were collected from each patient, as well as from 22 non-HBV infected individuals (to serve as healthy controls) .The various T lymphocyte subsets (CD3+, CD4+, and CD8+) were detected by flow cytometry and expressed as percentages of the entire T lymphocyte cell population.HBV DNA presence and quantity was assessed by fluorescence real-time polymerase chain reaction.Differences between groups were assessed by the Kruskal-Wallis H test.Pairwise comparisons were made by Dunnett's test and multiple comparisons were made by the least significant difference test.Results Compared to the healthy control group, all four of the HBV-infected groups showed significantly less peripheral blood T cell percentages of CD3+ (all, P<0.01) and CD4+ (all, P<0.01) ;however, only the HBV-infected groups of HBV-related cirrhosis and HCC showed significantly less percentages of CD8+ (P<0.05) .none="" of="" the="" hbv-infected="" groups="" showed="" a="" significantly="" different="" ratio="" from="" that="" detected="" in="" healthy="" control="" group="" p="">0.05) .There was a general trend in decreasing percentages of the peripheral blood T cell subsets that followed increases in hepatitis disease progression (HBV carriers>CHB>HBV-related cirrhosis>HBV-related HCC) .Conclusion Progression of the HBV infection to more severe forms of liver disease is accompanied by ebbs in the CD3+, CD4+, and CD8+ T cell subsets.Significantly differential profiles of immunomodulatory cell types may represent useful targets of novel therapeutic strategies tailored to the various progressive forms of CHB.
- hepatitis B /
- T lymphocyte subsets

HTML全文

参考文献(19)

[1]Li HB, Jiang XP, Ye J, et al.Clinical Value of testing periph-eral blood T lymphocyte subsets in patients with chronic hep-atitis B[J].Anhui Med Pharm J, 2006, 10 (8) :588-589. (in Chinese) 李鸿宾, 江晓萍, 叶珺, 等.测定慢性乙型肝炎患者外周血T淋巴细胞亚群的临床意义[J].安徽医药, 2006, 10 (8) :588-589.

[2]Liu Y, Han YP, Li J, et al.Detection the Lymphocyte Sub-sets of the Peripheral Blood from the Patients with ChronicHepatitis B[J].Acta Academia Medicinal Nantong, 2004, 24 (2) :140-141. (in Chinese) 刘源, 韩亚萍, 李军, 等.慢性乙型肝炎患者外周血淋巴细胞亚群的测定分析[J].南通医学院院报, 2004, 24 (2) :140-141.

[3]Yin Y, Zhang YH, Zhang LC.Significance of the changes ofthe levels of TNF-αand sIL-2R and CD4/CD8 in patientswith hepatitis B[J].Immunol J, 2001, 18 (1) :74-75. (inChinese) 殷樱, 张盈华, 张利朝.乙肝病程发展中CD4/CD8、TNF-α、sIL-2R水平变化及意义[J].免疫学杂志, 2001, 18 (1) :74-75.

[4]Li JQ, Zhou JY.The role of immune cells in immune toler-ance mechanisms towards chronic hepatitis B[J].J ClinHepatol, 2011, 27 (4) :437-440. (in Chinese) 李俊卿, 周俊英.免疫细胞在慢性乙型肝炎免疫耐受机制中的作用[J].临床肝胆病杂志, 2011, 27 (4) :437-440.

[5]Peng WW.Modern infectious diseases and infectious disea-ses[M].Beijing:Science press, 2000:617. (in Chinese) 彭文伟.现代感染性疾病与传染病学[M].北京:科学出版社, 2000:617.

[6]Zhang Z, Wang FS.Current perspectives on immune patho-genesis and immune therapy of chronic hepatitis B[J].JClin Hepatol, 2012, 28 (11) :801-804. (in Chinese) 张政, 王福生.慢性乙型肝炎免疫致病机制和免疫治疗现状[J].临床肝胆病杂志, 2012, 28 (11) :801-804.

[7]Luo KX.Hepatitis B basic and clinical[M].Beijing:People’smedical publishing house, 2001:188-189. (in Chinese) 骆抗先.乙型肝炎基础和临床[M].北京:人民卫生出版社, 2001:188-189.

[8]Li JY, Yang J, Jia HY, et al.Differences in peripheral T-cellsubsets among different clinical types of hepatitis B patients.[J].World Chin J Dig, 2009, 17 (29) :3038-3042. (inChinese) 刘俊英, 杨京, 贾红云, 等.不同临床类型HBV感染者外周血T细胞亚群的差异[J].世界华人消化杂志, 2009, 17 (29) :3038-3042.

[9]Qiao YW, You J, Chen HY, et al.Comparative analysis ofperipheral T-cell subsets and liver histopathology in asymp-tomatic hepatitis B virus carriers[J].World Chin J Dig, 2005, 13 (21) :2554-2558. (in Chinese) 乔燕伟, 游晶, 陈红英, 等.HBV携带者T细胞亚群状况与肝组织病理学对比[J].世界华人消化杂志, 2005, 13 (21) :2554-2558.

[10]Li M, Li W.Relation of peripherol T-cell subsets variation inchronic heptatitis B.virus infected subjects[J].J ModernClin Med Bioengineering, 2002, 8 (1) :36-36. (in Chi-nese) 李鸣, 林蔚.慢性乙型肝炎患者外周血T淋巴细胞亚群的变化[J].现代临床医学生物工程学杂志, 2002, 8 (1) :36.

[11]Tian Y, Qiu ZF, Li TS.Difference and significance of periph-eral blood T-lymphocyte subsets in patients with chronichepatitis B and asympomatic HBV carries.[J].Natl Med JChin, 2005, 85 (47) :3354-3358. (in Chinese) 田瑛, 邱志峰, 李太生.慢性乙型肝炎患者和乙型肝炎病毒携带者外周血T细胞亚群的变化和意义[J].中华医学杂志, 2005, 85 (47) :3354-3358.

[12]Xu D, Fu J, Jin L, et al.Circulation and liver resident CD+CD25+regularory T cells actively influence the antively influ-ence the antitiviral immune response and disease[J].Immu-nol, 2006, 177:739-747.

[13]Wang H, Gao JP, You J.Relation of peripherol T-cell subsetsvariation and HBV-DNA levels in chronic heptatitis B.virus in-fected subjects[J].P Clin Med, 2012, 21 (6) :418-422. (inChinese) 王辉, 高建鹏, 游晶.慢性乙型肝炎病毒感染者外周血T细胞亚群变化与其血清HBV DNA的水平分析[J].临床医药实践, 2012, 21 (6) :418-422.

[14]Wang XH, Yang R, Lei XZ, et al.Chronic hepatitis B patientdividing and peripheral blood T lymphocyte subsets of the re-lationship[J].S Med J, 2005, 26 (10) :1087-1088. (inChinese) 王晓辉, 杨尧, 雷学忠, 等.慢性乙型肝炎患者病情分度与外周血T淋巴细胞亚群的关系[J].四川医药, 2005, 26 (10) :1087-1088.

[15]Xu DZ.Viral hepatitis clinical practice[M].Beijing:People’smedical publishing house, 2006:137-158. (in Chinese) 徐道振.病毒性肝炎临床实践[M].北京:人民卫生出版社, 2006:137-158.

[16]Zhang XY, Wang L, Yu HY.The influence of adefovir dipiv-oxil on peripheral blood lymphocyte subsets in treatment ofpatients with chronic hepatitis B[J].J Clin Exp Med, 2011, 10 (23) :181-1820. (in Chinese) 张小玉, 王雷, 俞海英, 等.阿德福韦酯抗病毒治疗对慢性乙肝患者免疫功能的影响[J].临床和实验医学杂志, 2011, 10 (23) :1818-1820.

[17]Li WY, Jiang YF, Jin QL.et al.Immunologic characterizationof post hepatitis cirrhosis caused by HBV and HCV infection[J].J Biomed Biotechnol, 2010, 2010:138237.

[18]Yang J, He J, Lu H, et al.Molecular features of the comple-mentarity determining region 3 motif of the T cell populationand subsets in the blood of patients with chronic severe hep-atitis B[J].J Transl Med, 2011, 9:210.

[19]Sari F, Taskapan H.Good response to HBsAg vaccine in dial-ysis patients is associated with high CD4+/CD8+T ratio[J].Int Urol Nephrol, 2012, 44 (5) :1501-1506.

施引文献

资源附件(0)

访问统计